Biomedical drug re-engineering using supercritical fluid (SCF) technology to create sub-micron particles with improved solubility and bioavailability, for enhanced drug design and delivery
Develop technology to manufacture therapeutic proteins through genetic modification of gastrointestinal cells to find a cure for diabetes and its complications